Rathbones Group’s Rocket Pharmaceuticals RCKT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-20,000	Closed	-$70.2K	–	665
2025 Q4	$70.2K	Hold	20,000	–	–	﹤0.01%	614
2025 Q3	$65.2K	Hold	20,000	–	–	﹤0.01%	620
2025 Q2	$49K	Sell	20,000 -10,000	-33%	-$50.7K	﹤0.01%	604
2025 Q1	$200K	Hold	30,000	–	–	﹤0.01%	531
2024 Q4	$377K	Hold	30,000	–	–	﹤0.01%	450
2024 Q3	$554K	Hold	30,000	–	–	﹤0.01%	403
2024 Q2	$646K	Hold	30,000	–	–	﹤0.01%	375
2024 Q1	$808K	Hold	30,000	–	–	﹤0.01%	349
2023 Q4	$899K	Hold	30,000	–	–	0.01%	329
2023 Q3	$615K	Buy	+30,000	New	+$545K	﹤0.01%	367
2021 Q3	–	Sell	-5,000	Closed	-$221K	–	434
2021 Q2	$221K	Hold	5,000	–	–	﹤0.01%	391
2021 Q1	$222K	Hold	5,000	–	–	﹤0.01%	369
2020 Q4	$274K	Buy	+5,000	New	+$182K	﹤0.01%	338
2018 Q1	–	Sell	-2,500	Closed	-$26K	–	327
2017 Q4	$26K	Hold	2,500	–	–	﹤0.01%	314
2017 Q3	$18K	Hold	2,500	–	–	﹤0.01%	317
2017 Q2	$19K	Hold	2,500	–	–	﹤0.01%	316
2017 Q1	$20K	Hold	2,500	–	–	﹤0.01%	322
2016 Q4	$61K	Hold	2,500	–	–	﹤0.01%	305
2016 Q3	$95K	Buy	+2,500	New	+$78.6K	﹤0.01%	297

Other funds holding RCKT